MTOR and cancer: Of the remaining articles, 27 studies were ruled out because of the following reason: expression level of mTOR/p-mTOR not measured (21), no data about HRs but median survival time or 5-year survival rate (3), no data about OS but cancer specific survival (CSS) or progression free survival (PFS).